Status:
UNKNOWN
Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
40+ years
Brief Summary
This cohort study compares immune response induced in two groups of small HCC patients treated by ablation (group1 RFA, group 2 MWA). Patients will benefit for tumoral and non tumoral biopsies prior t...
Eligibility Criteria
Inclusion
- Histologically proven HCC for less than 3 months before ablation
- Decision of ablation treatment in multidisciplinary meeting
Exclusion
- Fibrolamellar HCC
- Hepatocholangiocarcinoma
Key Trial Info
Start Date :
May 31 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04892810
Start Date
May 31 2021
End Date
June 30 2022
Last Update
May 19 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.